Candel Therapeutics (CADL) Non-cash Items: 2020-2023
Historic Non-cash Items for Candel Therapeutics (CADL) over the last 3 years, with Sep 2023 value amounting to $3.5 million.
- Candel Therapeutics' Non-cash Items rose 29.98% to $3.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $3.5 million, marking a year-over-year increase of 29.98%. This contributed to the annual value of $881,000 for FY2022, which is 96.66% down from last year.
- According to the latest figures from Q3 2023, Candel Therapeutics' Non-cash Items is $3.5 million, which was up 6.94% from $3.3 million recorded in Q2 2023.
- In the past 5 years, Candel Therapeutics' Non-cash Items ranged from a high of $13.8 million in Q4 2020 and a low of $881,000 during Q4 2022.
- Its 3-year average for Non-cash Items is $2.3 million, with a median of $2.4 million in 2022.
- Per our database at Business Quant, Candel Therapeutics' Non-cash Items slumped by 85.15% in 2021 and then spiked by 129.23% in 2022.
- Quarterly analysis of 4 years shows Candel Therapeutics' Non-cash Items stood at $13.8 million in 2020, then slumped by 85.15% to $2.1 million in 2021, then slumped by 57.07% to $881,000 in 2022, then grew by 29.98% to $3.5 million in 2023.
- Its Non-cash Items stands at $3.5 million for Q3 2023, versus $3.3 million for Q2 2023 and $3.1 million for Q1 2023.